îæ€çŽ¢
îæ€çŽ¢
î
Bicara Therapeutics Inc
BCAXîãŠã©ãããªã¹ãã«è¿œå
19.650USD
-0.835-4.08%
ååŒæé 09/24, 12:49ïŒETïŒ
1.29Bæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
æ ªäž»
æŽæ°æå»: Sun, May 10
æŽæ°æå»: Sun, May 10
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
RA Capital Management, LP
11.04%
T. Rowe Price Investment Management, Inc.
10.05%
Biocon Ltd.
8.41%
Invus Public Equities Advisors, LLC
7.94%
Vestal Point Capital, LP
5.44%
ä»ã®
57.11%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
RA Capital Management, LP
11.04%
T. Rowe Price Investment Management, Inc.
10.05%
Biocon Ltd.
8.41%
Invus Public Equities Advisors, LLC
7.94%
Vestal Point Capital, LP
5.44%
ä»ã®
57.11%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Investment Advisor
43.95%
Investment Advisor/Hedge Fund
19.24%
Venture Capital
14.47%
Hedge Fund
9.57%
Corporation
8.96%
Private Equity
4.91%
Research Firm
1.80%
Individual Investor
1.28%
Bank and Trust
0.17%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Apr 1
æŽæ°æå»: Wed, Apr 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2026Q1
287
61.73M
94.10%
-4.15M
2025Q4
224
50.30M
113.92%
-100.00
2025Q3
224
50.29M
114.26%
-993.95K
2025Q2
199
51.28M
94.95%
+2.59M
2025Q1
174
48.67M
90.18%
-499.81K
2024Q4
146
46.83M
73.19%
+7.00M
2024Q3
76
39.67M
0.00%
+39.67M
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
RA Capital Management, LP
7.26M
11.08%
+300.00K
+4.31%
Feb 26, 2026
T. Rowe Price Investment Management, Inc.
3.24M
4.94%
+2.77M
+596.45%
Dec 31, 2025
Biocon Ltd.
5.52M
8.44%
+5.41M
+4671.98%
Apr 14, 2025
Invus Public Equities Advisors, LLC
5.22M
7.97%
--
--
Dec 31, 2025
Vestal Point Capital, LP
3.58M
5.46%
-1.52M
-29.90%
Dec 31, 2025
Red Tree Management, LLC
3.17M
4.84%
--
--
Dec 31, 2025
TPG Capital, L.P.
3.01M
4.6%
--
--
Dec 31, 2025
Deep Track Capital LP
2.75M
4.2%
+136.00K
+5.20%
Feb 12, 2026
Janus Henderson Investors
2.65M
4.04%
+2.65M
--
Dec 31, 2025
Fidelity Management & Research Company LLC
2.41M
3.68%
+773.38K
+47.18%
Dec 31, 2025
詳现ãèŠã
ETF
îæŽæ°æå»: Sat, Dec 6
æŽæ°æå»: Sat, Dec 6
éæå
æ¯ç
Virtus LifeSci Biotech Clinical Trials ETF
0.95%
Hypatia Women CEO ETF
0.37%
ALPS Medical Breakthroughs ETF
0.37%
Fidelity Enhanced Small Cap ETF
0.06%
T Rowe Price Small-Mid Cap ETF
0.05%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.03%
iShares Russell 2000 Value ETF
0.03%
ProShares Hedge Replication ETF
0.02%
iShares Russell 2000 ETF
0.02%
Global X Russell 2000 ETF
0.02%
詳现ãèŠã
Virtus LifeSci Biotech Clinical Trials ETF
æ¯ç0.95%
Hypatia Women CEO ETF
æ¯ç0.37%
ALPS Medical Breakthroughs ETF
æ¯ç0.37%
Fidelity Enhanced Small Cap ETF
æ¯ç0.06%
T Rowe Price Small-Mid Cap ETF
æ¯ç0.05%
JPMorgan BetaBuilders US Small Cap Equity ETF
æ¯ç0.03%
iShares Russell 2000 Value ETF
æ¯ç0.03%
ProShares Hedge Replication ETF
æ¯ç0.02%
iShares Russell 2000 ETF
æ¯ç0.02%
Global X Russell 2000 ETF
æ¯ç0.02%